Tagged with Trend

Key Biopharma Executive Changes in 2024: CEOs Stay Put, New AI Roles, Stalwarts Depart
Is 2022 the Pharma Industry’s ‘Call of Duty’ Moment?
Further Predictions for 2019 – Tech, Value-Based Pricing & Emerging Markets
Interview: Rami El-Cheikh – National Pharma & Life Sciences Leader, PwC Canada
Rafael Gual Cosío – Director General, CANIFARMA, Mexico
Interview: Anne-Christine Marie – Partner in charge of the Pharma and Life sciences Division, PwC France
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here